InvestorsHub Logo
Followers 32
Posts 10384
Boards Moderated 0
Alias Born 04/20/2016

Re: agamemnus post# 394

Saturday, 09/09/2017 12:27:19 PM

Saturday, September 09, 2017 12:27:19 PM

Post# of 449
They are not that big in the US. Plus it is yet to be seen what risk they are assuming the first few years to market this.

Why did the idiot board go along with prabda and most likely hundreds of millions of dollars hiring a salesforce for a product that wasn't even approved?

Salary, car, computers, insurance and severance for what, nothing. The lawyers suing Cemp should drill down on that.

Didn't she say after the manufacturing issue that the delay was fine because the product would have been best launched 6 months later when doctors would be more receptive because of flu season.

Your big pharma is big in Italy and some of EU but they don't have a big presence here. 70 reps is a start but more than likely double that will be needed. And the big question is how much risk they take rolling this out.

Why isn't a big US pharma on this, those reps would have multiple products to showcase. Right now, your big pharma is not impressive at all

I hope I am wrong but these Cemp people are idiots as far as I can see. Why would they agree to pay 8 mil if the deal doesn't go through, that is bullshit.

And to think that this is trading underwater if liquidation value is crazy. They might have to reverse split the stock just to meet Nasdaq requirements